Sabin Vaccine Institute

Sabin is driven by science-based approaches to combating diseases. Sabin not only advocates and provides treatments, we develop them. Research and development are at our core. That’s why we’re particularly proud of our partnership with the George Washington University and other international organizations. Working together, we’ve created the first-ever vaccine development program against human hookworm infection, a devastating neglected tropical disease affecting 570 million people living in the world’s poorest countries. In 2000, we established a unique product development partnership known as the Human Hookworm Vaccine Initiative. As a result, our human hookworm vaccines are now undergoing clinical testing in Brazil. Simultaneously, we are developing vaccines for schistosomiasis, another important neglected tropical disease, which is now ravaging entire communities across the globe - especially in Africa and in the poorest areas of Latin America. Moreover, through our international programs in vaccine advocacy and sustainable immunization financing, we are working to ensure that even the very poorest people have access to essential vaccines and that their governments build capacity to procure vaccines and deliver these life-saving products. Through our Global Network for Neglected Tropical Diseases, we advocate and mobilize resources to ensure that urgently needed treatments and essential medicines for the seven most common neglected tropical diseases are delivered to world’s poorest people by working through established public private partnerships on the ground in Africa, Asia, and the Americas, together with the World Health Organization and its regional offices, national health ministries, and the affected communities. Source: www.sabin.org